Combining Alk‐F1178S with Th‐MYCN resulted in a significant increase in the aggressiveness of tumour development, exemplified by complete tumour penetrance at 30 wk together with markedly earlier tumour onset, averaging 8 wk (Fig 3D and E). This evidence concerns the gene ALK and neoplasm.